![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 8, 2003.
Revised June 11, 2003.
Accepted for publication June 23, 2003.
Glucocorticoids are widely used as potent anti-
inflammatory drugs. Glucocorticoids exert their
pharmacological effects by binding to a glucocorticoid
receptor (GR), which promotes expression of its target
genes, or suppresses transcription mediated by other
transcriptional factors, such as NF-
B. In order
to identify genetic polymorphisms affecting
glucocorticoid responses, the GR gene were sequenced and
two novel single nucleotide alterations, 1510A>T (T504S)
and 1952C>T (S651F), were identified in addition to an
adenine base insertion at nucleotide 2314 (2314insA).
mRNA expression levels of T504S and S651F were comparable
to that of the wild type (WT), whereas the mRNA level of
2314insA was reduced to ~36% of the WT level. Protein
expression was reduced to ~66% of WT levels in S651F and
to ~6% in 2314insA. No significant change was seen in
the T504S variant levels. The instability of the 2314insA
mRNA, S651F protein, and 2314insA protein was confirmed
by time-course experiments. The transcriptional activity
of S651F and 2314insA was also reduced to approximately
63% and 2% of the WT levels, respectively, in the
luciferase reporter assay. Moreover, the inhibitory
effect of GR on NF-
B transactivation was reduced
to approximately 81% and 12% of the WT levels for S651F
and 2314insA, respectively. These results indicated that
the overall transcriptional activity and inhibitory
effect on NF-
B transactivation of S651F and
2314insA have partially reduced and almost abrogated,
respectively, almost paralleling their reduced protein
expression levels caused by mRNA and/or protein
instabilities. Thus, these two variations were suggested
to influence the response to glucocorticoid treatment.
Key words:
functional change, glucocorticoid receptor, nuclear factor-kappaB, single nucleotide polymorphism, stability, transcription
This article has been cited by other articles:
![]() |
S. Koyano, Y. Saito, H. Fukushima-Uesaka, S. Ishida, S. Ozawa, N. Kamatani, H. Minami, A. Ohtsu, T. Hamaguchi, K. Shirao, et al. FUNCTIONAL ANALYSIS OF SIX HUMAN ARYL HYDROCARBON RECEPTOR VARIANTS IN A JAPANESE POPULATION Drug Metab. Dispos., August 1, 2005; 33(8): 1254 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koyano, K. Kurose, Y. Saito, S. Ozawa, R. Hasegawa, K. Komamura, K. Ueno, S. Kamakura, M. Kitakaze, T. Nakajima, et al. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION Drug Metab. Dispos., January 1, 2004; 32(1): 149 - 154. [Abstract] [Full Text] [PDF] |
||||